Motif Pharmaceuticals Ltd.

Insider Reports History

Location
Dublin, Ireland
Signature
Motif Pharmaceuticals Ltd., By /s/ Zachary Klein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Motif Pharmaceuticals Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Chromocell Therapeutics Corp 10%+ Owner Common Stock 470,674 $2,259,235 $4.80 15 Feb 2024 Direct

Insider Reports Filed by Motif Pharmaceuticals Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CHRO Chromocell Therapeutics Corp 15 Feb 2024 0 $0 3 10%+ Owner 15 Feb 2024, 20:36